SCOTUS pauses new limits on abortion pill; weight-loss startup Calibrate cuts workforce

Taking stock of the drug industry, from the lab to the medicine chest

April 14, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Evan Vucci/AP Supreme Court pauses new limits on abortion pill, pending further review next week Access to the abortion pill mifepristone will remain unchanged until Wednesday, after a U.S. Supreme Court justice stayed last week's ban. By Sarah Owermohle STAT+ | Weight-loss startup Calibrate cuts 18% of workforce as obesity drugs spark growing competition The telehealth company plans to focus more on partnering with employers to provide services to their workers. By Elaine Chen Opinion: I'm a biopharma supply chain specialist — and even I can't find the Adderall I'm prescribed Even a biopharmaceutical supply chain expert can't find prescribed ADHD medication, thanks to the Adderall shortage. By Guadalupe Hayes-Mota Justin Sullivan/Getty Images The Biden administration will hang on to some Covid pandemic emergency powers While the Biden HHS is ending its most high-profile Covid-19 emergency declaration next month, it will hold on to some pandemic-era powers. By Rachel Cohrs STAT+ | UnitedHealth says medical costs aren't soaring. The reality is murkier UnitedHealth says medical costs aren't soaring. But its stock fell more than 2% on fears those costs are eating into its insurance business. By Bob Herman STAT+ | 'Style over substance?' Express Scripts launches new pricing plan amid rising scrutiny of PBMs The move toward more transparency comes as Congress and the U.S. Federal Trade Commission are taking steps to probe pharmacy benefit managers By Ed Silverman and John Wilkerson Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser